Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma 5Lymphoma, B-Cell, Marginal Zone 4Lymphoma, Follicular 3Leukemia 3Waldenstrom Macroglobulinemia 2Neoplasms 2Leukemia, B-Cell 2Stomach Neoplasms 1Hodgkin Disease 1

Interventions

ibrutinib 4Rituximab 4fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2idelalisib 2Whole-Body Irradiation 2Mycophenolic Acid 2Epoetin Alfa 2Early Intervention, Educational 2Darbepoetin alfa 2Cyclosporins 2Cyclosporine 2Chlorambucil 2zanubrutinib 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vancomycin 1Tazobactam 1Sucrose 1Sirolimus 1Psychiatric Rehabilitation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmacogenomic Testing 1Ondansetron 1Morphine 1Ketamine 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Waldenstrom Macroglobulinemia × Chlorambucil × Clear all
NCT00566332 2015-08-19

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

French Study Group on Chronic Lymphoid Leukemia

Phase 3 Completed
414 enrolled
Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT00608374 2013-08-26

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Lymphoid

Lymphoma, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡